As CEO, Morris Miller is responsible for Xenex’s overall business strategy and oversight of day-to-day operations. He is also founder of Sequel and Cutstone Ventures, where he invests in and acts as an advisor to numerous startup and established technology companies such as Inventables, OptimizedNow and Golfballs.com. Previously, Morris was co-founder and President/CEO of Rackspace Hosting, which now has more than 175,000 customers, over $1 billion in annual revenue, and with a market cap in excess of $4 billion. Prior to Rackspace, Morris started Curtis Hill Publishing, the first company to publish Texas case law on CD-ROM. Early in his career Morris was an attorney at Matthews & Branscomb, now part of Cox Smith, San Antonio’s oldest and largest law firm. He is an alumnus of Phillips Exeter Academy, The University of Texas at Austin and The Southern Methodist University School of Law.

Dr. Stachowiak is a Founder of Xenex, and as its Chief Epidemiologist, she is responsible for efficacy reporting, monitoring, evaluation and data quality assurance with a focus on statistical validity. She establishes and recommends protocols for healthcare facilities utilizing Xenex’s technology, and evaluates their infection control results help them achieve maximum results utilizing Xenex’s recommended best practices standards. Dr. Stachowiak also oversees research study design, grant application and manuscript preparation, frequently in conjunction with Xenex’s customers. Dr. Stachowiak is an infectious disease epidemiologist who received her doctoral degree at the Johns Hopkins School of Public Health. She has been involved in research and program implementation in Russia and the former Soviet Union since 1993, including NIH, USAID and Global Fund research. She also holds Masters degrees in Public Health and International Affairs from Columbia University. In 1993, Dr. Stachowiak co-founded AIDS infoshare, a Russian organization committed to lessening the suffering caused by HIV/AIDS. From 2003-2005, she was a member of the faculty of the Johns Hopkins School of Public Health.

Dr. Stibich is a Founder of Xenex, and as its Chief Scientific Officer, he oversees scientific research, product development, facility assessments, and protocol design. He leads new technology development and is an inventor on multiple patents. Dr. Stibich meets frequently with infection prevention representatives at healthcare facilities, helping them understand and solve their infection control problems while analyzing hospital results. He has conducted CEU sessions for APIC chapters and presented at SHEA and AHE conferences, and is regarded as a thought leader in the infection control community. Dr. Stibich holds a doctoral degree from the Johns Hopkins University School of Public Health, a Masters in Health Science, also from Johns Hopkins, and a bachelor’s degree from Yale University. He has conducted research in Russia, Tajikistan, Afghanistan, South Africa, Kenya, the United States and Brazil.

Enda Flynn is executive vice president of business development for Xenex Healthcare Services.  In addition to Xenex, Enda is the co-founder of Connell Curtis Group, The Positioning Experts, which provides business consulting services and invests in startups. Previously, Enda managed all aspects of the AT&T account for EMC Consulting. He also served as BusinessEdge’s broadband competency lead and as executive director of product management at AT&T, where he directed product marketing and deployment of transport services. Prior to that, Enda was executive director of business development at AT&T, where he successfully delivered the strategic alliance with Yahoo! Inc. Enda earned his MBA from Washington University in St. Louis, MO, and holds a bachelor’s degree in Electronic and Electrical Engineering from University College Dublin in Ireland.

Glenn is the Director of the Transplant Center at the University of Texas Health Science Center at San Antonio. He received his medical degree at the University of Texas Medical School in Houston, Texas. Glenn completed his residency and internship at New York University in New York City, New York and his transplant fellowship at the University of Pittsburgh. In 1992, he started the liver transplant program at University of Texas Health Science Center at San Antonio where he performs adult and pediatric liver and kidney transplants.

Matthew Rhodes-Kropf is a member of the Entrepreneurial Management Unit at Harvard Business School, where he teaches courses on Venture Capital and Private Equity in the MBA elective curriculum and in executive education programs. Matthew specializes in mergers and acquisitions, venture capital, and corporate governance. He has published in leading finance and economic journals, including The Journal of Finance, The RAND Journal of Economics, and The Journal of Business. A graduate of Duke University, Matthew Rhodes-Kropf holds a BA in computer science and economics and an MA and Ph.D. in economics.

A. J. is an advisor and strategist to physician groups and hospitals with over 30 years of experience in the management and administration of hospitals and physician group practices. He has held senior management or consulting positions at IBM Healthcare Consulting, Innovative Managed Care Systems, Tenet Healthcare, Booz, Allen & Hamilton, as well as a national PPO. He received a BS from Indiana University and an MBA from the University of Louisville. He has been a board member of a number of major healthcare organizations and is a frequent speaker as a healthcare subject matter expert.

John is currently the CEO/Executive Director of the Bexar County Medical Society, representing over 4,000 physicians in central Texas. He was previously CFO of Northeast Metropolitan Methodist Hospitals in San Antonio for eight years and CFO at Nix Healthcare System for thirteen years. John also served as chairman of the Greater San Antonio Hospital Council.